acetylcysteine has been researched along with Anankastic Personality in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.57) | 29.6817 |
| 2010's | 21 (75.00) | 24.3611 |
| 2020's | 6 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Berk, M; Blair-West, S; Boschen, M; Bousman, C; Brakoulias, V; Byrne, G; Camfield, D; Castle, D; Chamoli, S; Cribb, L; Dean, OM; Dowling, N; Ee, C; Jordan, R; Karamacoska, D; Menon, R; Metri, NJ; Murphy, J; Ng, CH; Nguyen, TP; Oliver, G; Rossell, SL; Sarris, J; Wong, A | 1 |
| Back, SE; Berk, M; Bradlow, RCJ; Kalivas, PW; Kanaan, RA | 1 |
| Iwata, N; Kishi, T; Sakuma, K | 1 |
| Gales, BJ; Gales, MA; Parli, GM | 1 |
| Jafferany, M; Nwankwo, CO | 1 |
| Filip, M; Frankowska, M; Smaga, I | 1 |
| Campbell, EH; Hwang, AS; Sartori-Valinotti, JC | 1 |
| Bloch, MH; Costa, DLC; Diniz, JB; Joaquim, MA; Miguel, EC; Pittenger, C; Requena, G; Shavitt, RG | 1 |
| Banaschewski, T; Dijkhuizen, RM; Dittmann, RW; Durston, S; Glennon, JC; Häge, A; K Buitelaar, J; Mechler, K; Murphy, D; Schweinfurth, N; Tactics Consortium, T; Williams, S | 1 |
| Moore, K | 1 |
| di Michele, F; Niolu, C; Siracusano, A; Talamo, A | 1 |
| Couto, JP; Moreira, R | 1 |
| Allen, EM; Anderson, CJ; Hughes, EF; Woehrle, NS | 1 |
| Braun, TL; DeBord, LC; Patel, V; Rosen, T | 1 |
| Bhaskara, S | 1 |
| Percinel, I; Yazici, KU | 3 |
| Racz, R; Sohoni, P; Sweet, BV | 1 |
| Berk, M; Blair-West, S; Camfield, DA; Dean, OM; Dowling, N; Menon, R; Murphy, J; Ng, CH; Oliver, G; Sarris, J; Smith, DJ | 1 |
| Giaroli, G; Smith, L; Tracy, DK | 1 |
| Ahmadipour, A; Akamaloo, A; Akhondzadeh, S; Emamzadehfard, S; Paydary, K; Pishgar, F | 1 |
| Chamberlain, SR; Grant, JE; Kim, SW; Leppink, EW; Odlaug, BL; Redden, SA | 1 |
| Alvarenga, PG; Bloch, MH; Jakubovski, E; Landeros-Weisenberger, A; Leckman, JF; Mulqueen, JM; Panza, KE; Yaffa, A | 1 |
| Berk, M; Camfield, DA; Sarris, J | 1 |
| Abe, M; Egashira, N; Fujiwara, M; Iwasaki, K; Mishima, K; Niki, T; Oishi, R; Shirakawa, A | 1 |
| Afshar, H; Hafezian, H; Haghighi, M; Jahangard, L; Mohammad-Beigi, H; Roohafza, H; Sadeghi, M; Shokouh, P | 1 |
| Coric, V; Gardner, T; Kelmendi, B; Krystal, JH; Lafleur, DL; Malison, RT; Pittenger, C; Sanacora, G; Wasylink, S | 1 |
12 review(s) available for acetylcysteine and Anankastic Personality
| Article | Year |
|---|---|
The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders.
Topics: Acetylcysteine; Anxiety Disorders; Bipolar Disorder; Humans; Obsessive-Compulsive Disorder; Schizophrenia | 2022 |
Mitochondrial modulators for obsessive-compulsive and related disorders: a systematic review and meta-analysis.
Topics: Acetylcysteine; Adult; Double-Blind Method; Female; Humans; Inositol; Lithium; Male; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic | 2022 |
"N-Acetylcysteine for Obsessive-Compulsive and Related Disorders in Children and Adolescents: A Review".
Topics: Acetylcysteine; Adolescent; Adult; Child; Child, Preschool; Cognitive Behavioral Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2023 |
N-Acetylcysteine in psychodermatological disorders.
Topics: Acetylcysteine; Dermatology; Female; Humans; Male; Nail Biting; Obsessive-Compulsive Disorder; Prognosis; Projective Techniques; Severity of Illness Index; Skin Diseases; Treatment Outcome; Trichotillomania | 2019 |
N-acetylcysteine as a new prominent approach for treating psychiatric disorders.
Topics: Acetylcysteine; Animals; Anxiety; Anxiety Disorders; Bipolar Disorder; Humans; Obsessive-Compulsive Disorder | 2021 |
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature.
Topics: Acetylcysteine; Adolescent; Attention Deficit Disorder with Hyperactivity; Autism Spectrum Disorder; Brain; Child; Corpus Striatum; Excitatory Amino Acid Agents; Glutamic Acid; Humans; Memantine; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Receptors, Glutamate; Risk Assessment; Treatment Outcome | 2018 |
N-Acetyl Cysteine and Vitamin D Supplementation in Treatment Resistant Obsessive-compulsive Disorder Patients: A General Review.
Topics: Acetylcysteine; Animals; Dietary Supplements; Humans; Inflammation; Neuroprotective Agents; Obsessive-Compulsive Disorder; Vitamin D | 2018 |
Oral N-acetylcysteine in the treatment of obsessive-compulsive disorder: A systematic review of the clinical evidence.
Topics: Acetylcysteine; Administration, Oral; Humans; Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic | 2018 |
A review of N-acetylcysteine in the treatment of grooming disorders.
Topics: Acetylcysteine; Free Radical Scavengers; Humans; Nail Biting; Obsessive-Compulsive Disorder; Trichotillomania | 2019 |
Oral acetylcysteine for neuropsychiatric disorders.
Topics: Acetylcysteine; Administration, Oral; Autistic Disorder; Bipolar Disorder; Complementary Therapies; Dietary Supplements; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Schizophrenia; Trichotillomania | 2015 |
What Future Role Might N-Acetyl-Cysteine Have in the Treatment of Obsessive Compulsive and Grooming Disorders?: A Systematic Review.
Topics: Acetylcysteine; Adult; Child; Free Radical Scavengers; Humans; Obsessive-Compulsive Disorder; Oxidative Stress; Randomized Controlled Trials as Topic | 2016 |
Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence.
Topics: 5-Hydroxytryptophan; Acetylcysteine; Dietary Supplements; Glycine; Humans; Hypericum; Inositol; Obsessive-Compulsive Disorder; Plant Preparations; Signal Transduction; Silybum marianum; Tryptophan | 2011 |
7 trial(s) available for acetylcysteine and Anankastic Personality
| Article | Year |
|---|---|
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial.
Topics: Acetylcysteine; Double-Blind Method; Humans; Obsessive-Compulsive Disorder; Quality of Life; Treatment Outcome | 2022 |
Randomized, Double-Blind, Placebo-Controlled Trial of N-Acetylcysteine Augmentation for Treatment-Resistant Obsessive-Compulsive Disorder.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Anxiety Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Young Adult | 2017 |
N-Acetyl Cysteine (NAC) in the Treatment of Obsessive-Compulsive Disorder: A 16-Week, Double-Blind, Randomised, Placebo-Controlled Study.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Analysis of Variance; Double-Blind Method; Female; Follow-Up Studies; Free Radical Scavengers; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2015 |
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Fluvoxamine; Humans; Iran; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2016 |
N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Glutamic Acid; Humans; Male; Middle Aged; Nucleus Accumbens; Obsessive-Compulsive Disorder; Self-Injurious Behavior; Skin; Young Adult | 2016 |
N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial.
Topics: Acetylcysteine; Adolescent; Anxiety; Attention Deficit Disorder with Hyperactivity; Child; Depression; Double-Blind Method; Female; Free Radical Scavengers; Humans; Linear Models; Male; Obsessive-Compulsive Disorder; Severity of Illness Index; Tics; Tourette Syndrome; Treatment Outcome | 2016 |
N-acetylcysteine add-on treatment in refractory obsessive-compulsive disorder: a randomized, double-blind, placebo-controlled trial.
Topics: Acetylcysteine; Adult; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Young Adult | 2012 |
9 other study(ies) available for acetylcysteine and Anankastic Personality
| Article | Year |
|---|---|
Evidence of N-acetylcysteine efficacy for skin picking disorder: A retrospective cohort study.
Topics: Acetylcysteine; Humans; Obsessive-Compulsive Disorder; Retrospective Studies; Self-Injurious Behavior; Skin; Skin Diseases | 2022 |
N-Acetyl Cysteine and Curcumin in Pediatric Acute-Onset Neuropsychiatric Syndrome.
Topics: Acetylcysteine; Acute Disease; Child, Preschool; Curcumin; Female; Humans; Neurodevelopmental Disorders; Obsessive-Compulsive Disorder; Syndrome; Treatment Outcome | 2018 |
N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Free Radical Scavengers; Humans; Male; Mice; Obsessive-Compulsive Disorder; Receptor, Serotonin, 5-HT1B; Task Performance and Analysis | 2018 |
N-Acetylcysteine augmentation in refractory obsessive–compulsive disorder
Topics: Acetylcysteine; Adult; Antioxidants; Drug Synergism; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Serotonin Agents | 2019 |
Glutamatergic dysfunction in skin-picking disorder: treatment of a pediatric patient with N-acetylcysteine.
Topics: Acetylcysteine; Child; Female; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Self-Injurious Behavior; Skin; Treatment Outcome | 2014 |
The role of glutamatergic dysfunction in treatment-resistant obsessive-compulsive disorder: treatment of an adolescent case with N-acetylcysteine augmentation.
Topics: Acetylcysteine; Adolescent; Female; Glutamic Acid; Humans; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales | 2014 |
N-Acetylcysteine Augmentation in Children and Adolescents Diagnosed With Treatment-Resistant Obsessive-Compulsive Disorder: Case Series.
Topics: Acetylcysteine; Adolescent; Child; Drug Therapy, Combination; Female; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2015 |
N-acetyl-L-cysteine inhibits marble-burying behavior in mice.
Topics: Acetylcysteine; alpha-Tocopherol; Animals; Antipsychotic Agents; Anxiety Disorders; Behavior, Animal; Fluvoxamine; Male; Mianserin; Mice; Mice, Inbred ICR; Mirtazapine; Motor Activity; Obsessive-Compulsive Disorder | 2012 |
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder.
Topics: Acetylcysteine; Drug Resistance; Drug Synergism; Female; Fluvoxamine; Humans; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors | 2006 |